GMAB
🔪 An investor case study showed selling Genmab after a 32% loss prevented a much larger 65% decline, highlighting the ‘assassin’ strategy.
⏱️ Setting predefined stop-loss levels, like 20-33%, can protect capital by forcing sales before drawdowns become unrecoverable.
📉 While cutting losses limits upside if a stock recovers, it crucially preserves capital for future, potentially better opportunities.
@adriarivero:
“A real case is Genmap. An investor bought shares of Genmap at 18.34 pounds. Two weeks later, the shares dropped 30%, and he sold everything upon reaching a -32% loss. Result: if he had held on, the stock would have fallen 65%. He would have needed a 286% return just to recover the investment. Assassins know that it’s not about avoiding losses, but about ensuring they are small.”
Watch the exact part of the video where @adriarivero talks about Genmab here:
Watch the video on YouTube
Read more articles analyzing Genmab (GMAB) at the provided link. GMAB stock.
